The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Agenda
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
To read the full story from the source: New York Times – Home






